ACSL4 and plasma cell myeloma: These data suggest that specific targeting of ACSL4 in the tumor environment may enable more specific effects on myeloma cells with a sparing of immune side effects, and demonstrate the complex nature of lipid metabolism influences on immune cell function in cancer.